# A Novel Approach to Infantile Spasms

> **NCT03347526** · PHASE3 · SUSPENDED · sponsor: **University of Colorado, Denver** · enrollment: 394 (estimated)

## Conditions studied

- Infantile Spasm

## Interventions

- **DRUG:** Cosyntropin Injectable Suspension, 1 mg/mL
- **DRUG:** Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin
- **DRUG:** Vigabatrin

## Key facts

- **NCT ID:** NCT03347526
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-04-19
- **Primary completion:** 2021-06
- **Final completion:** 2021-08
- **Target enrollment:** 394 (ESTIMATED)
- **Why stopped:** Study on enrollment hold as a precaution per the pharmaceutical company.
- **Last updated:** 2021-05-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03347526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03347526, "A Novel Approach to Infantile Spasms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03347526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*